StonvexLoading…
StonvexStonvexStonvexCore line items from BAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.70B | $11.24B | $8.27B | $5.43B |
Operating Income | $66.00M | $-308.00M | $421.00M | $249.00M |
Net Income | $-15.00M | $-957.00M | $171.00M | $217.00M |
EPS (Diluted) | $-0.03 | $-1.87 | $0.33 | $0.42 |
Total Assets | $19.85B | $20.05B | $21.07B | $21.05B |
Total Liabilities | $13.83B | $13.95B | $13.85B | $13.75B |
Cash & Equivalents | $2.02B | $1.97B | $1.73B | $1.69B |
Free Cash Flow OCF − CapEx | Not available | $332.00M | Not available | Not available |
Shares Outstanding | 515.00M | 513.00M | 514.00M | 514.00M |